Anti-HIV activity and mode of action of naturally occurring peptides interfering with the viral entry process
Exploration of the role of HIV envelope glycans on virus entry and the antiviral activity of carbohydrate-binding agents (CBAs)
Anti-HIV activity and mode of action of naturally occurring peptides interfering with the viral entry process
The role of cellular oxidoreductases in viral entry and virus infection-associated oxidative stress: potential therapeutic applications
Characterization of clinical respiratory syncytial virus isolates and the effect of protease inhibitors on early viral entry
Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes.
Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120